The Food and Drug Administration last week alerted health care providers and patients that batteries in certain Medtronic implantable pacemakers and cardiac resynchronization therapy pacemakers may drain more quickly than expected without warning. The devices provide pacing for slow heart rhythms and heart failure. FDA said it has received three reports of the batteries draining early because of a crack in the device’s capacitor, resulting in one patient’s death. FDA recommends that providers advise their patients to continue to use their remote monitors, which can be set to alert the patient and provider when the battery level drops below a certain limit, and to immediately replace the device if they receive such a notice.
 

Related News Articles

Headline
The Food and Drug Administration today reported 55 injuries and one death involving an infusion pump and vital signs monitoring system. Becton Dickinson…
Headline
The Food and Drug Administration today announced a voluntary pilot program to expedite approvals of certain changes to ethylene oxide sterilization processes…
Headline
The Food and Drug Administration should study potential alternatives to ethylene oxide for sterilizing medical devices, but a solution could be at least a…
Headline
The Food and Drug Administration today recommended medical device manufacturers, health care providers and patients take certain actions to reduce the risk…
Headline
To reduce risk of patient infection, the Food and Drug Administration recommends health care facilities transition to using duodenoscopes with disposable…
Headline
Medtronic has recalled certain MiniMed insulin pumps due to cybersecurity risks, and will provide alternative pumps to the estimated 4,000 U.S. patients using…